Premium
Fibrinogen concentrates for bleeding trauma patients: what is the evidence?
Author(s) -
Meyer M. A. S.,
Ostrowski S. R.,
Windeløv N. A.,
Johansson P. I.
Publication year - 2011
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/j.1423-0410.2011.01478.x
Subject(s) - fibrinogen , medicine , fresh frozen plasma , prothrombin complex concentrate , randomized controlled trial , platelet , platelet transfusion , surgery , coagulopathy , prothrombin time , intensive care medicine , platelet concentrate , warfarin , atrial fibrillation
A balanced transfusion of red blood cells, fresh frozen plasma and platelets are recommended for massively bleeding trauma patients. Fibrinogen concentrates could potentially lessen or replace the need for fresh frozen plasma and/or platelet transfusions. Objective To provide a review of the literature covering the application of fibrinogen concentrates in trauma care. Methods PubMed and Cochrane database search, ‘fibrinogen’ and (‘concentrate’ or ‘trauma’), not ‘congenital’, 10 years. Results Only four papers were identified. None were randomized controlled trials. The main conclusion of these papers was that administration of fibrinogen sometimes together with prothrombin complex concentrate might improve haemostasis in trauma patients resuscitated with synthetic colloids. Conclusion Evidence for the use of fibrinogen concentrate to trauma patients with massive bleeding is lacking. Well‐designed prospective, randomized, double‐blinded studies evaluating the effect of fibrinogen concentrate, as the only intervention, are urgently needed.